Characterization of the anti-Leishmania effect induced by cisplatin, an anticancer drug

Acta Tropica

Volumn 103, Issue 2, 2007, Pages 133-141

  Tavares, J ^a,b,d   Ouaissi, M ^c   Ouaissi, A ^b,d,e   Cordeiro da Silva, A ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c HÔPITAL SAINTE MARGUERITE   (France)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^e INSERM   (France)

Author keywords

Anticancer drug; Cell death; Cisplatin; Leishmania infantum

Indexed keywords

CISPLATIN; DNA FRAGMENT; GLUTATHIONE; GLUTATHIONE DISULFIDE; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE;

CANCER; CHEMOTHERAPY; DNA; DRUG; FLOW CYTOMETRY;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DISEASE CARRIER; DRUG SENSITIVITY; FLOW CYTOMETRY; IC 50; LEISHMANIA; LEISHMANIA INFANTUM; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PROMASTIGOTE; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DEATH; CISPLATIN; DNA, PROTOZOAN; GLUTATHIONE; GLUTATHIONE DISULFIDE; IN SITU NICK-END LABELING; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LIFE CYCLE STAGES; MEMBRANE POTENTIAL, MITOCHONDRIAL; PHOSPHATIDYLSERINES; REACTIVE OXYGEN SPECIES;

HEXAPODA; LEISHMANIA INFANTUM; VERTEBRATA;

EID: 34547938095     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2007.05.017     Document Type: Article

References (31)

1. Ameisen J.C., Idziorek T., Billaut-Mulot O., Loyens M., Tissier J.P., Potentier A., and Ouaissi A. Apoptosis in a unicellular eukaryote (Trypanosoma cruzi): implications for the evolutionary origin and role of programmed cell death in the control of cell proliferation, differentiation and survival. Cell Death Differ. 2 (1995) 285-300
2. Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113 (1985) 548-555
3. Berman J.D. Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24 (1997) 684-703
4. Croft S.L. In vitro screens in the experimental chemotherapy of leishmaniasis and trypanosomiasis. Parasitol. Today 2 (1986) 64-69
5. Croft S.L., and Coombs G.H. Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol. 19 (2003) 502-508
6. Das G.C., Bacsi A., Shrivastav M., Hazra T.K., and Boldogh I. Enhanced gammaglutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity. Mol. Carcinogen. 45 (2006) 635-647
7. Dzamitika S., Salerno M., Pereira-Maia E., Le Moyec L., and Garnier-Suillerot A. Preferential energy- and potential-dependent accumulation of cisplatin-glutathione complexes in human cancer cell lines (GLC4 and K562): a likely role of mitochondria. J. Bioenerg. Biomembr. 38 (2006) 11-21
8. Ehrenberg B., Montana V., Wei M.D., Wuskell J.P., and Loew L.M. Membrane potential can be determined in individual cells from the Nernstian distribution of cationic dyes. Biophys. J. 53 (1988) 785-794
9. Fuertes M.A., Castilla J., Alonso C., and Pérez J.M. Novel concepts in the development of platinum antitumor drugs. Curr. Med. Chem. Anti-Cancer Agents 2 (2002) 539-551
10. Guevara P., Ramirez J.L., Rojas E., Scorza J.V., Gonzalez N., and Anez N. Leishmania braziliensis in blood 30 years after cure. Lancet 341 (1993) 1341
11. Hirji N., Lin T.J., Bissonnette E., Belosevic M., and Befus A.D. Mechanisms of macrophage stimulation through CD8: macrophage CD8alpha and CD8beta induce nitric oxide production and associated killing of the parasite Leishmania major. J. Immunol. 15 (1998) 6004-6011
12. Huang H., Zhu L., Reid B.R., Drobny G.P., and Hopkins P.B. Solution structure of a cisplatin-induced DNA interstrand cross-link. Science 270 (1995) 1842-1845
13. Jansen B.A., Brouwer J., and Reedijk J. Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs. J. Inorg. Biochem. 89 (2002) 197-202
14. Kamata H., and Hirata H. Redox regulation of cellular signalling. Cell Signal. 11 (1999) 1-11
15. Kawai Y., Nakao T., Kunimura N., Kohda Y., and Gemba M. Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. J. Pharmacol. Sci. 100 (2006) 65-72
16. Lee N., Bertholet S., Debrabant A., Muller J., Duncan R., and Nakhasi H.L. Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ. 9 (2002) 53-64
17. Mandic A., Viktorsson K., Strandberg L., Heiden T., Hansson J., Linder S., and Shoshan M.S. Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol. Cell. Biol. 22 (2002) 3003-3013
18. Mandic A., Hansson J., Linder S., and Shoshan M.C. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signalling. J. Biol. Chem. 278 (2003) 9100-9106
19. Modabber F. Vaccines against leishmaniasis. Ann. Trop. Med. Parasitol. 89 Suppl. 1 (1995) 83-88
20. Murry H.W. Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob. Agents Chemother. 45 (2001) 2185-2197
21. Nguewa P.A., Fuertes M.A., Iborra S., Najajreh Y., Gibson D., Martínez E., Alonso C., and Pérez J.M. Water soluble cationic trans-platinum complexes which induce programmed cell death in the protozoan parasite Leishmania infantum. J. Inorg. Biochem. 99 (2005) 727-736
22. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., and Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139 (1991) 271-279
23. Ormerod M.G., O'Neill C.F., Robertson D., and Harrap K.R. Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp. Cell Res. 211 (1994) 231-237
24. Osuna A., Ruiz-Perez L.M., Lopez M.C., Castanys S., Gamarro F., Craciunescu D.G., and Alonso C. Antitrypanosomal action of cis-diamminedichloroplatinum(II) analogs. J. Parasitol. 73 (1987) 272-277
25. Ouaissi, M., 2004. Etude in vitro et in vivo de la sensibilité des cellules tumorales pancréatiques exprimant l'épitope alpha (α) Gal aux drogues chimiothérapeutiques. Diplôme d'Etudes Approfondies des Sciences Chirurgicales. Université Paris VI.
26. Oullette M., and Papadopoulou B. Mechanisms of drug resistance in Leishmania. Parasitol. Today 5 (1993) 150-153
27. Sato T., Suzuki M., Sato Y., Echigo S., and Rikiishi H. Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells. Int. J. Oncol. 28 (2006) 1233-1241
28. Sorenson C.M., and Eastman A. Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. Cancer Res. 48 (1988) 6703-6707
29. Tavares J., Ouaissi A., Lin P.K., Tomas A., and Cordeiro-da-Silva A. Differential effects of polyamine derivative compounds against Leishmania infantum promastigotes and axenic amastigotes. Int. J. Parasitol. 35 (2005) 637-646
30. Vaisman A., Varchenko M., Said I., and Chaney S.G. Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity. Cytometry 27 (1997) 54-64
31. Zamzami N., Maisse C., Metivier D., and Kroemer G. Measurement of membrane permeability and permeability transition of mitochondria. Methods Cell Biol. 65 (2001) 147-158